Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002

Infection

Volumn 33, Issue 5-6, 2005, Pages 333-339

  Kern, W V ^a   De With, K ^a   Steib Bauert, M ^a   Fellhauer, M ^b   Plangger, A ^c   Probst, W ^d   Amann, S ^e   Schmid, Nina ^e   Hofmann, Susanne ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

^c KLINIK AM EICHERT   (Germany)

^d Klinikum Heidenheim   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; FLUCLOXACILLIN; GENTAMICIN; GLYCOPEPTIDE; LEVOFLOXACIN; MEZLOCILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; DATA ANALYSIS; DRUG DOSE REGIMEN; DRUG SURVEILLANCE PROGRAM; GERMANY; GYNECOLOGY; HOSPITAL CARE; HOSPITAL PHARMACY; HUMAN; INTENSIVE CARE UNIT; INTERDISCIPLINARY COMMUNICATION; INTERNAL MEDICINE; PHARMACOEPIDEMIOLOGY; PREDICTION; PRESCRIPTION; SURGICAL WARD;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG UTILIZATION; FLUOROQUINOLONES; GERMANY; GLYCOPEPTIDES; HEALTH FACILITY SIZE; HOSPITAL DEPARTMENTS; HOSPITALS, GENERAL; HUMANS; INTENSIVE CARE UNITS; INTERNAL MEDICINE; SURGERY DEPARTMENT, HOSPITAL;

EID: 27644476928     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-005-5059-3     Document Type: Article

References (22)

1. Meyer E, Jonas D, Schwab F, Rüden H, Gastmeier P, Daschner FD: Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 2003; 31: 208-215.
2. Kern WV, Rose AD, Hay B, Muche R, Frank U, and the Baden-Württemberg Interuniversity Study Group: Antimicrobial expenditures and usage at four university hospitals. Infection 2001; 29: 127-137.
3. Kern WV, de With K, Trautmann M, Kern P, Gonnermann C: Glycopeptide use at four university hospitals in southern Germany. Infection 2002; 30: 262-266.
4. Kern WV, de With K, Gonnermann C, Strehl E, and the MABUSE-INTERUNI-II project team: Update on glycopeptide use in German university hospitals. Infection 2004; 32: 157-162.
5. de With K, Bergner J, Bühner R, Dorje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Steib-Bauert M, Kern WV: Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II). Int J Antimicrob Agents 2004; 24: 213-218.
6. de With K, Bergner J, Bühner R, Dorje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Steib-Bauert M, Kern WV: Antibiotikaanwendung an deutschen Hochschulkliniken (Projekt INTERUNI-II). Ergebnisse für medizinische Kliniken unter Berücksichtigung von Intensivpflegestationen, onkologischen Stationen und sonstigen Pflegebereichen. Med Klin 2004; 99: 347-354.
7. de With K, Steib-Bauert M, Bergner J, Bühner R, Dörje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Daschner FD, Kern WV: Antibiotikaanwendung an chirurgischen Universitätskliniken (Projekt INTERUNI-II). Krankenhauspharmazie 2004; 11: 478-483.
8. de With K, Schröder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kämmerer R, Ruess S, Daschner FD, Kern WV: Antibiotikaanwendung in Deutschland im europäischen Vergleich. Dtsch Med Wochenschr 2004; 129: 1987-1992.
9. Janknegt R, Wijnands WJ, Caprasse M, Brandenburg W, Schuitenmaker MG, Stobberingh E: Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993; 12: 832-838.
10. NORM/NORM-VET 2002. Consumption of antimicrobial agents and occurrence of resistance in Norway. University Hospital of North Norway, Tromsø, Norway, 2003.
11. SWEDRES 2003. A Report on Swedish antibiotic utilisation and resistance in human medicine. ISSN 1400-3473. Swedish Strategic Programme for the Rational Use of Antimicrobial Agents (STRAMA) and the Swedish Institute for Infectious Disease Control, Solna, Sweden, 2003.
12. DANMAP 2003. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Danish Veterinary Institute, Copenhagen, Denmark, 2003.
13. Gould IM, Jappy B: Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother 2000; 45: 913-917.
14. Hermosilla NL, Canut BA, Ulibarrena SM, Abasolo OE, Abecia I: Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf 2003; 12: 243-247.
15. Vlahovic-Palcevski V, Morovic M, Palcevski G, Betica-Radic L: Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol 2001; 17: 375-383.
16. Petersen IS, Hesselbjerg L, Jorgensen L, Renstrup J, Barnung S, Schierbeck J, Jepsen OB: High antibiotic consumption in Danish intensive care units? APMIS 1999; 107: 989-996.
17. Kiivet RA, Dahl ML, Llerena A, Maimets M, Wettermark B, Berecz R: Antibiotic use in 3 European university hospitals. Scand J Infect Dis 1998;30:277-280.
18. Mazzeo F, Capuano A, Motola G, Russo F, Berrino L, Filippelli A, Rossi F: Antibiotic use in an Italian university hospital. J Chemother 2002; 14:332-335.
19. Naaber P, Koljalg S, Maimets M: Antibiotic usage and resistance - trends in Estonian university hospitals. Int J Antimicrob Agents 2000; 16: 309-315.
20. Vlahovic-Palcevski V, Morovic M, Palcevski G: Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000; 56: 97-101.
21. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksson B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H: Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 2002; 46: 1075-1081.
22. Filius PM, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, Verbrugh HA: An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother; 2005; 55: 805-808.